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CHAPTER 1 
 
 
 
 
INTRODUCTION 
 
 
 
 
1.1 Introduction 
 
 
Many glycoproteins have been produced by a variety of expression systems 
including cell cultures of mammalian or insect cell lines.  Of particular interest has 
been the baculovirus expression system that generates high levels of recombinant 
proteins from insect cells such as Spodoptera frugiperda (Sf-9).  The potential 
production of therapeutic glycoproteins in these systems has stimulated the desire to 
monitor the glycosylation pattern of specific insect-cell-produced glycoproteins and 
the glycosylation potential of insect cells in general.  The glycan moieties can 
significantly affect a protein’s stability, biological activity, antigenicity, 
immunogenicity, solubility, cellular processing, secretion and pharmacokinetic 
behaviour such as in vivo metabolic clearance rate (Takeuchi et al., 1990, Takeuchi 
and Kobata, 1991, Munk et al., 1992).  
 
 
It is well documented that the N-glycans found in recombinant glycoproteins 
expressed by lepidopteran cells using the baculovirus vector are predominantly high 
mannose type glycans and short truncated glycans (paucimannose) with α1,3/ α1,6-
linked fucose residue on its asparagines-bound N-acetylglucosamine (GlcNAc) 
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(Jarvis and Summers, 1989; Wathen et al., 1991; Grabenhorst et al.,1993; Yeh et al., 
1993; Manneberg et al., 1994; Ogonah et al.,1995; Hsu et al.,1997; Opez et al., 
1997).  In contrast, mammalian cells usually produce sialylated complex-type N-
glycans.  Generation of complete forms of sialylated complex-type N-glycans in 
insect cells may increase the value of insect cell derived products as vaccines, 
therapeutic and diagnostics. 
 
 
The glycosylation process in the cultured cells can be controlled by various 
factors, which are sugar acceptor as model protein, substrate donor also known as 
sugar nucleotide and glycosyltransferase as enzyme.  Activity measurements of 
several glycosyltransferases involved in the elongation of N-glycans have 
demonstrated that insect cells contain α1,6-fucosyltransferase (Staudacher et 
al.,1992) and a significant level of β1,2-N-acetylglucosaminyltransferase I activities 
(Velardo et al.,1993, Altmann et al.,1993) but they lack significant β1,4-
galactosyltransferase (Butters et al.,1981; van Die et al., 1996) and sialytransferase 
activities (Hooker et al., 1999).  In addition to glycosyltransferases, another 
important factor in protein glycosylation is the sugar nucleotides essential in the 
biosynthesis of glycoconjugates.  Since these are the substrate donor of 
glycosyltransferases that construct the glycan chains, the intracellular levels of sugar 
nucleotides can affect the glycosylation potential of the cultured cells as well.   
 
 
In this study, we will focus on the galactosylation processing pathway rather 
than the whole glycosylation process.  In the galactosylation process, recombinant 
human transferrin (hTf) is the substrate acceptor, β1,4-galactosyltransferase (β-
1,4GalT) is the glycosyltransferase, and uridine-5’-diphosphogalactose (UDP-Gal) is 
the substrate donor.  Recombinant hTf will be used as a model protein simply due to 
its simple biantennary N-glycan structure.  Ailor et al. (2000) revealed that the N-
glycan structures of hTf produced in insect cells included high mannose, 
paucimannosidic, and hybrid structures with over 50% these structures containing 
one or two fucoses linked to the Asn-linked N-acetylglucosamine.  Furthermore, 
neither sialic acid nor galactose was detected on any of the N-glycan. 
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In this study, establishment of the native UDP-Gal level at normal and upon 
baculovirus infection was performed.  It is proposed that analysis of the intracellular 
concentration of sugar nucleotides could provide important information on the 
potential of galactosylation in Sf-9 insect cells as little is known about the level of 
native UDP-Gal level especially upon baculovirus infection.  To evaluate the quality 
of the recombinant hTf, different levels of galactosylation were conducted to obtain 
the galactosylated hTf, including in vivo and in vitro study.  In vivo refers to the 
baculovirus coinfection by coexpressing β-1,4GalT and hTf simultaneously in 
cultured cell, meanwhile the introduction of commercial GalT and UDP-Gal to the 
hTf after it was secreted from insect cell cultures called as in vitro.  
 
 
 
 
1.2 Objectives 
 
 
(1) To develop a method for the expression of galactosylated recombinant hTf in 
insect cells 
(2) To optimize the expression of the galactosylated recombinant hTf  
 
 
 
 
1.3 Scopes of Research 
 
 
(1) Recloning of recombinant virus stock, virus propagation and virus titration 
(2) Establishment of an assay system for the detection of β1,4-GalT and UDP-Gal 
(3) Monitoring of native UDP-Gal level at normal and upon baculovirus infection 
(4) Evaluation of the quality of the glycoprotein obtained through baculovirus 
coinfection study to coexpress β1,4-GalT and hTf (in vivo study) and the  
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artificial introduction of commercial GalT and UDP-Gal to secreted hTf (in  
vitro study) 
